# Inflammation and Coronary Endothelial Function

> **NCT02366091** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 111 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02366091
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2021-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02366091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02366091, "Inflammation and Coronary Endothelial Function". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02366091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*